| UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
|||||||
|
Kinase Fusion Gene:AKT2_SMIM17 |
Kinase Fusion Protein Summary |
Kinase Fusion gene summary |
| Kinase Fusion partner gene information | Kinase Fusion gene name: AKT2_SMIM17 | KinaseFusionDB ID: KFG278 | FusionGDB2.0 ID: KFG278 | Hgene | Tgene | Gene symbol | AKT2 | SMIM17 | Gene ID | 208 | 147670 | |
| Gene name | AKT serine/threonine kinase 2 | small integral membrane protein 17 | ||||||||||
| Synonyms | HIHGHH|PKBB|PKBBETA|PRKBB|RAC-BETA | - | ||||||||||
| Cytomap | 19q13.2 | 19q13.43 | ||||||||||
| Type of gene | protein-coding | protein-coding | ||||||||||
| Description | RAC-beta serine/threonine-protein kinasePKB betaRAC-PK-betamurine thymoma viral (v-akt) homolog-2protein kinase Akt-2protein kinase B betaputative v-akt murine thymoma viral oncoprotein 2rac protein kinase betav-akt murine thymoma viral oncogene h | small integral membrane protein 17 | ||||||||||
| Modification date | 20240413 | 20240305 | ||||||||||
| UniProtAcc | P31751 | P0DL12 | ||||||||||
| Ensembl transtripts involved in fusion gene | ENST ids | ENST00000311278, ENST00000392038, ENST00000424901, ENST00000579047, ENST00000581582, | ENST00000598409, ENST00000600547, | |||||||||
| Context (manual curation of fusion genes in KinaseFusionDB) | PubMed: AKT2 [Title/Abstract] AND SMIM17 [Title/Abstract] AND fusion [Title/Abstract] | |||||||||||
| Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | AKT2(40762833)-SMIM17(57156936), # samples:1 | |||||||||||
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | AKT2 | GO:0030335 | positive regulation of cell migration | 25428377 |
Kinase Fusion gene breakpoints across AKT2 (5'-gene)* Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Kinase Fusion gene breakpoints across SMIM17 (3'-gene)* Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Kinase Fusion Gene Sample Information |
Kinase Fusion gene information. |
Kinase Fusion gene information from four resources (ChiTars 5.0, ChimerDB 4.0, COSMIC, and CCLE)* All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Sample | Hgene | Hchr | Hbp | Tgene | Tchr | Tbp |
| ChimerDB4 | TCGA-K1-A6RU-01A | AKT2 | chr19 | 40762833 | SMIM17 | chr19 | 57156936 |
Top |
Kinase Fusion ORF Analysis |
Kinase Fusion information from ORFfinder translation from full-length transcript sequence from KinaseFusionDB. |
| Henst | Tenst | Hgene | Hchr | Hbp | Tgene | Tchr | Tbp | Seq length (transcript) | Seq length (amino acids) |
Top |
Kinase Fusion Amino Acid Sequences |
For individual full-length fusion transcript sequence from KinaseFusionDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >Henst_Tenst_Hgene_Hchr_Hbp_Tgene_Tchr_Tbp_length(fusion AA)_AAseq |
Multiple Sequence Alignment of All Fusion Protein Isoforms |
Top |
Kinase Fusion Protein Functional Features |
Four levels of functional features of fusion genesGo to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:40762833/:57156936) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| AKT2 | SMIM17 |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- Retained domain in the 5'-partner of fusion protein (protein functional feature from UniProt). |
| Partner | Hgeneene | Hbp | Tgeneene | Tbp | ENST | BPexon | TotalExon | Protein feature loci | BPloci | TotalLen | Feature | Note |
- Retained domain in the 3'-partner of fusion protein (protein functional feature from UniProt). |
| Partner | Hgeneene | Hbp | Tgeneene | Tbp | ENST | BPexon | TotalExon | Protein feature loci | BPloci | TotalLen | Feature | Note |
Top |
Kinase-Substrate Information of AKT2_SMIM17 |
Phosphorylation target of the kinase(phosphosite, 03-17-2024) |
| Kinase | Kinase UniProt Acc | Kinase species | Substrate | Substrate UniProt Acc | Substrate phosphorylated residues | Substrate phosphorylated sites (+/-7AA) | Domain |
| AKT2 | P31751 | human | ATP7A | Q04656 | S1424 | SYELPARsQIGQKsP | |
| AKT2 | P31751 | human | PKP1 | Q13835 | S63 | ssQsstLsHsNRGsM | |
| AKT2 | P31751 | human | IRF3 | Q14653 | T180 | sPsLDNPtPFPNLGP | |
| AKT2 | P31751 | human | EGFR | P00533 | S229 | rCrGKSPsDCCHNQC | Furin-like |
| AKT2 | P31751 | human | PKP1 | Q13835 | T179 | LGsKGQKttQNRysF | |
| AKT2 | P31751 | human | EZR | P15311 | T567 | QGRDkyKtLRQIRQG | ERM_C |
| AKT2 | P31751 | human | CBY1 | Q9Y3M2 | S20 | TPPRKsAsLSNLHsL | Chibby |
| AKT2 | P31751 | human | HSF1 | Q00613 | S230 | PkYSRQFsLEHVHGS | |
| AKT2 | P31751 | human | BMI1 | P35226 | S316 | ANRPRKssVNGSSAT | |
| AKT2 | P31751 | human | ADAR | P55265 | T1033 | RLGERLRtMSCSDKI | A_deamin |
| AKT2 | P31751 | human | PKP1 | Q13835 | S191 | ysFystCsGQKAIKK | |
| AKT2 | P31751 | human | FLNC | Q14315 | S2233 | LGRERLGsFGsItRQ | Filamin |
| AKT2 | P31751 | human | PKP1 | Q13835 | T180 | GsKGQKttQNRysFy | |
| AKT2 | P31751 | human | IRS2 | Q9Y4H2 | S365 | sCRVRtAsEGDGGAA | |
| AKT2 | P31751 | human | H3C1 | P68431 | S10 | tkQtArkstGGkAPr | Histone |
| AKT2 | P31751 | human | WIPF1 | O43516 | T398 | TSRALPAtPQLPSrS | |
| AKT2 | P31751 | human | PKP1 | Q13835 | S127 | ysQMENWsRHYPRGS | |
| AKT2 | P31751 | human | EDC3 | Q96F86 | S161 | sFRRRHNsWssssRH | Edc3_linker |
| AKT2 | P31751 | human | ATP7A | Q04656 | S1466 | ysRAsINsLLsDkRs | |
| AKT2 | P31751 | human | PKP1 | Q13835 | S118 | EPDNRRFssysQMEN | |
| AKT2 | P31751 | human | PHB2 | Q99623 | S91 | RARPRkIssPTGSkD | Band_7 |
| AKT2 | P31751 | human | CHUK | O15111 | T23 | EMRERLGtGGFGNVC | Pkinase |
| AKT2 | P31751 | human | PHB2 | Q99623 | S176 | TERAKDFsLILDDVA | Band_7 |
| AKT2 | P31751 | human | H3C1 | P68431 | S28 | ATkAArksAPATGGV | Histone |
| AKT2 | P31751 | human | ADARB1 | P78563 | T553 | LQGERLLtMSCSDKI | A_deamin |
| AKT2 | P31751 | human | PKP1 | Q13835 | S65 | QsstLsHsNRGsMyD | |
| AKT2 | P31751 | human | LMNA | P02545 | S390 | EEErLRLsPsPtsQR | |
| AKT2 | P31751 | human | ATP7A | Q04656 | S1463 | IVNysRAsINsLLsD | |
| AKT2 | P31751 | human | PKP1 | Q13835 | T171 | RGtLRKGtLGsKGQK | |
| AKT2 | P31751 | human | PKP1 | Q13835 | T82 | ADNyNyGttsRssYy | |
| AKT2 | P31751 | human | IRF3 | Q14653 | S175 | PQPLRsPsLDNPtPF | |
| AKT2 | P31751 | human | PPIF | P30405 | S31 | LPAARACsKGsGDPS | |
| AKT2 | P31751 | human | PKP1 | Q13835 | T61 | sKssQsstLsHsNRG | |
| AKT2 | P31751 | human | GAPDH | P04406 | T237 | GMAFrVPtANVsVVD | Gp_dh_C |
| AKT2 | P31751 | human | PKP1 | Q13835 | S69 | LsHsNRGsMyDGLAD | |
| AKT2 | P31751 | human | PKP1 | Q13835 | S174 | LRKGtLGsKGQKttQ | |
| AKT2 | P31751 | human | LMNA | P02545 | S404 | RsRGRAssHssQtQG | |
| AKT2 | P31751 | human | PKP1 | Q13835 | S54 | MTVKRQKsKssQsst | |
| AKT2 | P31751 | human | MAP3K5 | Q99683 | S83 | ATRGRGssVGGGSrR | |
| AKT2 | P31751 | human | HTRA2 | O43464 | S212 | RVRVRLLsGDTYEAV | Trypsin_2; Peptidase_M50 |
| AKT2 | P31751 | human | PKP1 | Q13835 | S185 | KttQNRysFystCsG | |
| AKT2 | P31751 | human | XIAP | P98170 | S87 | VGRHRKVsPNCRFIN | BIR |
| AKT2 | P31751 | human | PKP1 | Q13835 | S57 | KRQKsKssQsstLsH | |
| AKT2 | P31751 | human | IRF3 | Q14653 | S14 | RILPWLVsQLDLGQL | IRF |
| AKT2 | P31751 | human | CYCS | P99999 | Y47 | ktGQAPGysytAANk | Cytochrom_C |
| AKT2 | P31751 | human | IRS2 | Q9Y4H2 | S1149 | GGRRRHssEtFSsTt | |
| AKT2 | P31751 | human | UPF1 | Q92900 | T151 | FCNGRGNtSGSHIVN | UPF1_Zn_bind |
| AKT2 | P31751 | human | GATA6 | Q92908-2 | S290 | KPQKRVPsSRRLGLS | |
| AKT2 | P31751 | human | ESR1 | P03372 | S167 | GGRERLAsTNDkGSM | Oest_recep |
| AKT2 | P31751 | human | PKP1 | Q13835 | T166 | LyCDPRGtLRKGtLG | |
| AKT2 | P31751 | human | PKP1 | Q13835 | T189 | NRysFystCsGQKAI | |
| AKT2 | P31751 | human | FSCN1 | Q16658 | T403 | GCRkVTGtLDANRSS | Fascin |
| AKT2 | P31751 | human | RACGAP1 | Q9H0H5 | T249 | WTRSRRktGtLQPWN | |
| AKT2 | P31751 | human | IRS2 | Q9Y4H2 | S306 | EFRPRsksQssGssA | |
| AKT2 | P31751 | human | RPS6KA3 | P51812 | T115 | KVRDRVRtKMERDIL | |
| AKT2 | P31751 | human | NF2 | P35240 | S10 | GAIASRMsFSsLkRK | |
| AKT2 | P31751 | human | PKP1 | Q13835 | S188 | QNRysFystCsGQKA | |
| AKT2 | P31751 | human | PKP1 | Q13835 | S84 | NyNyGttsRssYySK | |
| AKT2 | P31751 | human | PKP1 | Q13835 | S60 | KsKssQsstLsHsNR | |
| AKT2 | P31751 | human | PKP1 | Q13835 | S121 | NRRFssysQMENWsR | |
| AKT2 | P31751 | human | KHSRP | Q92945 | S193 | GLPERsVsLtGAPEs | KH_1 |
| AKT2 | P31751 | human | PIP5K1C | O60331 | S555 | RYRRRtQssGQDGRP | |
| AKT2 | P31751 | human | MAT1A | Q00266 | T202 | VIPVRIHtIVISVQH | S-AdoMet_synt_M |
| AKT2 | P31751 | human | HSF1 | Q00613 | S326 | ssVDtLLsPTALIDs | Vert_HS_TF |
| AKT2 | P31751 | human | CTNNB1 | P35222 | S552 | QDtQRRtsMGGtQQQ | |
| AKT2 | P31751 | human | ANKRD2 | Q9GZV1 | S99 | QERVRKTsLDLRREI | |
| AKT2 | P31751 | human | IRS2 | Q9Y4H2 | S577 | GLRKRtysLttPARQ | |
| AKT2 | P31751 | human | IRF3 | Q14653 | T207 | EEWEFEVtAFYRGRQ | IRF-3 |
| AKT2 | P31751 | human | C2CD5 | Q86YS7 | S197 | EARQRLIsLMsGELQ | |
| AKT2 | P31751 | human | SH3RF1 | Q7Z6J0 | S304 | KNTKKRHsFtsLtMA | |
| AKT2 | P31751 | human | PDK1 | Q15118 | T346 | APRPRVEtsRAVPLA | HATPase_c |
| AKT2 | P31751 | human | PKP1 | Q13835 | S59 | QKsKssQsstLsHsN | |
| AKT2 | P31751 | human | H3C1 | P68431 | T45 | PHryrPGtVALrEIR | Histone |
| AKT2 | P31751 | human | PKP1 | Q13835 | S119 | PDNRRFssysQMENW | |
| AKT2 | P31751 | human | EPRS1 | P07814 | S999 | NQGGGLsssGAGEGQ | |
| AKT2 | P31751 | human | WIPF1 | O43516 | S154 | PGrFPVPsPGHRSGP | |
| AKT2 | P31751 | human | PKP1 | Q13835 | S56 | VKRQKsKssQsstLs | |
| AKT2 | P31751 | human | MAT1A | Q00266 | S180 | LPWLRPDsKTQVTVQ | S-AdoMet_synt_M |
Biological Network Integration of This Kinase and Substrates (GeneMANIA website) |
Enriched GO biological processes of the phosphorylation target genes of the kinase |
| Kinase | GOID | GO term | P.adjust |
| AKT2 | ID | Description | 0.00e+00 |
| AKT2 | GO:0034599 | cellular response to oxidative stress | 9.95e-05 |
| AKT2 | GO:0062197 | cellular response to chemical stress | 2.64e-04 |
| AKT2 | GO:0034614 | cellular response to reactive oxygen species | 4.30e-04 |
| AKT2 | GO:0071276 | cellular response to cadmium ion | 4.30e-04 |
| AKT2 | GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 4.30e-04 |
| AKT2 | GO:0006979 | response to oxidative stress | 5.07e-04 |
| AKT2 | GO:0052548 | regulation of endopeptidase activity | 5.85e-04 |
| AKT2 | GO:2000116 | regulation of cysteine-type endopeptidase activity | 7.62e-04 |
| AKT2 | GO:0052547 | regulation of peptidase activity | 7.73e-04 |
| AKT2 | GO:0000302 | response to reactive oxygen species | 8.13e-04 |
| AKT2 | GO:0046686 | response to cadmium ion | 1.24e-03 |
| AKT2 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress | 1.40e-03 |
| AKT2 | GO:0002221 | pattern recognition receptor signaling pathway | 1.40e-03 |
| AKT2 | GO:2001234 | negative regulation of apoptotic signaling pathway | 1.54e-03 |
| AKT2 | GO:0071456 | cellular response to hypoxia | 1.77e-03 |
| AKT2 | GO:0002758 | innate immune response-activating signaling pathway | 1.77e-03 |
| AKT2 | GO:0032481 | positive regulation of type I interferon production | 1.78e-03 |
| AKT2 | GO:0043122 | regulation of canonical NF-kappaB signal transduction | 1.95e-03 |
| AKT2 | GO:0036294 | cellular response to decreased oxygen levels | 1.99e-03 |
| AKT2 | GO:0002218 | activation of innate immune response | 2.19e-03 |
| AKT2 | GO:0051402 | neuron apoptotic process | 2.19e-03 |
| AKT2 | GO:0045088 | regulation of innate immune response | 2.35e-03 |
| AKT2 | GO:0071453 | cellular response to oxygen levels | 2.61e-03 |
| AKT2 | GO:0048732 | gland development | 2.61e-03 |
| AKT2 | GO:0001666 | response to hypoxia | 2.61e-03 |
| AKT2 | GO:0048145 | regulation of fibroblast proliferation | 2.61e-03 |
| AKT2 | GO:0007249 | canonical NF-kappaB signal transduction | 2.61e-03 |
| AKT2 | GO:0010464 | regulation of mesenchymal cell proliferation | 2.82e-03 |
| AKT2 | GO:0032872 | regulation of stress-activated MAPK cascade | 2.85e-03 |
| AKT2 | GO:0070302 | regulation of stress-activated protein kinase signaling cascade | 2.98e-03 |
| AKT2 | GO:0036293 | response to decreased oxygen levels | 2.99e-03 |
| AKT2 | GO:0097193 | intrinsic apoptotic signaling pathway | 3.10e-03 |
| AKT2 | GO:0002757 | immune response-activating signaling pathway | 3.10e-03 |
| AKT2 | GO:0043123 | positive regulation of canonical NF-kappaB signal transduction | 3.12e-03 |
| AKT2 | GO:0043086 | negative regulation of catalytic activity | 3.20e-03 |
| AKT2 | GO:0071248 | cellular response to metal ion | 3.24e-03 |
| AKT2 | GO:0010863 | positive regulation of phospholipase C activity | 3.32e-03 |
| AKT2 | GO:0071392 | cellular response to estradiol stimulus | 3.37e-03 |
| AKT2 | GO:0010586 | miRNA metabolic process | 3.37e-03 |
| AKT2 | GO:0048144 | fibroblast proliferation | 3.37e-03 |
| AKT2 | GO:1900274 | regulation of phospholipase C activity | 3.37e-03 |
| AKT2 | GO:0002764 | immune response-regulating signaling pathway | 3.37e-03 |
| AKT2 | GO:0045089 | positive regulation of innate immune response | 3.37e-03 |
| AKT2 | GO:0070482 | response to oxygen levels | 3.37e-03 |
| AKT2 | GO:0045216 | cell-cell junction organization | 3.57e-03 |
| AKT2 | GO:0032355 | response to estradiol | 3.87e-03 |
| AKT2 | GO:0010463 | mesenchymal cell proliferation | 4.42e-03 |
| AKT2 | GO:0071241 | cellular response to inorganic substance | 4.51e-03 |
| AKT2 | GO:0002833 | positive regulation of response to biotic stimulus | 4.51e-03 |
Top |
Related Drugs to AKT2_SMIM17 |
Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Drug | Source | PMID |
Distribution of the number of studies mentioning AKT2-SMIM17 and kinase inhibitors the PubMed Abstract (04-01-2024) |
| Fusion gene - drug pair 1 | Fusion gene - drug pair 2 | PMID | Publication date | DOI | Study title |
Top |
Related Diseases to AKT2_SMIM17 |
Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Disease | Source | PMID |
Related diseases from the literature mentioned this fusion gene and drug. (PubMed, 04-01-2024) |
| MeSH ID | MeSH term |
Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Top |
Clinical Trials of the Found Drugs/Small Molecules |
Statistics of the Clinical Trials of the Found Kinase Inibitors from clinicaltrials.gov (06-17-2024) |
Clinical Trials from clinicaltrials.gov (06-17-2024) |
| Fusion Gene | Kinase Inhibitor | NCT ID | Study Status | Phases | Disease | # Enrolment | Date |